Givaudan SA
F:GIN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Givaudan SA
F:GIN
|
CH |
|
Aligos Therapeutics Inc
NASDAQ:ALGS
|
US |
Wall St Price Targets
GIN Price Targets Summary
Givaudan SA
According to Wall Street analysts, the average 1-year price target for GIN is 3 048.65 EUR with a low forecast of 2 331.69 EUR and a high forecast of 4 195.44 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GIN's stock price target?
Price Target
3 048.65
EUR
According to Wall Street analysts, the average 1-year price target for GIN is 3 048.65 EUR with a low forecast of 2 331.69 EUR and a high forecast of 4 195.44 EUR.
What is the Revenue forecast for Givaudan SA?
Projected CAGR
4%
Over the last 14 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 7 years is 4%.
What is the Operating Income forecast for Givaudan SA?
Projected CAGR
4%
Over the last 14 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 7 years is 4%.
What is the Net Income forecast for Givaudan SA?
Projected CAGR
6%
Over the last 14 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 5 years is 6%.
